Maxim Group Reiterates Buy Rating on OXBR
Analyst Allen Klee maintains a buy rating with a $3.00 target for OXBR.
Key Points
- Maxim Group analyst Allen Klee reiterated a buy rating on OXBR with a $3.00 price target on June 17, 2026.
- Shares of OXBR are trading at $1.06, reflecting recent market activity and institutional adjustments.
- Insider Martin Allan sold shares multiple times, while institutional investors like Geode Capital and Vanguard Capital adjusted their holdings.
Maxim Group analyst Allen Klee reiterated his buy rating on OXBR on June 17, 2026, setting a price target of $3.00. The stock, which is currently trading at $1.06, has seen various institutional and insider activities that may interest investors.
Other Institutional Activity in OXBR
Geode Capital Management increased its holdings in OXBR by 10,607 shares, bringing its total to 166,043 shares valued at approximately $195,929. LPL Financial LLC maintained its position with 100,673 shares worth around $118,794. Henrickson Nauta Wealth Advisors, however, reduced its stake by 69,620 shares, now holding 67,780 shares valued at $79,980. Vanguard Capital Management started a new position with 58,483 shares valued at about $69,010. Meanwhile, International Assets Investment Management boosted its holdings by 18,227 shares to 48,000, valued at $53,760. Renaissance Technologies trimmed its position by 11,609 shares, ending with 32,700 shares worth $38,586.
Insider Buying and Selling at OXBR
Insider Martin Allan has been actively selling shares of OXBR. On April 16, 2026, Allan sold 135,134 shares at an average price of $0.7178. Additionally, he sold 4,328 shares at $2.4505 on September 16, 2025, and another 10,000 shares at $2.3859 on August 27, 2025. Earlier, on July 24, 2025, Allan sold 2,000 shares at an average price of $2.4333.
Analysts Set New Price Targets
On June 17, 2026, Maxim Group maintained its buy rating on OXBR with a price target of $3.00. This follows an earlier initiation of coverage with a buy rating and a $5.00 target on April 30, 2025. The consensus recommendation for OXBR remains positive, with analysts expecting the stock to reach the target price based on fundamentals.
About OXBR
OXBR operates in the financial sector, focusing on providing reinsurance services. The company is involved in underwriting insurance and reinsurance policies, serving various markets. Despite its niche focus, OXBR continues to attract attention from both analysts and institutional investors.
Bottom Line
Maxim Group's reiteration of a buy rating with a $3.00 target underscores ongoing interest in OXBR. The stock's current trading price of $1.06, coupled with significant insider sales and varied institutional activity, provides a dynamic backdrop for potential investors. As always, it's important to remember that analyst ratings and 13F filings reflect past positions and may not indicate current investment strategies.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.